Likes
Company Have Good policies as per global standard, Globally Amneal is good employer. But Raks pharma does not have the culture of amneal
read moreCompany name | Avg Annual Salary | Open Jobs |
---|---|---|
Sun Pharmaceutical Industries Junior Engineer Salary
1 - 3 years exp. (5 salaries) | ₹1.2 L/yr - ₹3.2 L/yr
31%
less | |
Cipla Junior Engineer Salary
0 - 6 years exp. (118 salaries) | ₹1.8 L/yr - ₹3.5 L/yr
8%
less | |
Login to view exact salary
| ||
Biocon Limited Junior Engineer Salary
0 - 7 years exp. (9 salaries) | ₹3 L/yr - ₹6.5 L/yr
27%
more | |
Lupin Junior Engineer Salary
0 - 6 years exp. (9 salaries) | ₹2 L/yr - ₹5.2 L/yr
21%
more | |
Zydus Lifesciences Junior Engineer Salary
1 - 2 years exp. (3 salaries) | ₹1.8 L/yr - ₹2.6 L/yr
26%
less | |
Aurobindo Pharma Junior Engineer Salary
1 - 4 years exp. (7 salaries) | ₹1.9 L/yr - ₹3 L/yr
14%
less | |
Glenmark Pharmaceuticals Junior Engineer Salary
0 - 4 years exp. (5 salaries) | ₹2 L/yr - ₹4 L/yr
6%
less | |
DIVI'S Laboratories Junior Engineer Salary
0 - 4 years exp. (11 salaries) | ₹2.2 L/yr - ₹3.6 L/yr
4%
less | |
MJ Biopharm Junior Engineer Salary
2 - 7 years exp. (17 salaries) | ₹3.6 L/yr - ₹4.9 L/yr
30%
more | |
Malladi Drugs & Pharmaceuticals Junior Engineer Salary
1 - 6 years exp. (11 salaries) | ₹2 L/yr - ₹3.8 L/yr
15%
less | |
Encube Ethicals Junior Engineer Salary
0 - 4 years exp. (9 salaries) | ₹2.1 L/yr - ₹3 L/yr
17%
less | |
Login to view exact salary
| ||
Optimus Drugs Junior Engineer Salary
3 - 6 years exp. (8 salaries) | ₹3 L/yr - ₹3.8 L/yr At par | |
Metrochem Api Junior Engineer Salary
1 - 4 years exp. (6 salaries) | ₹2.2 L/yr - ₹3.2 L/yr
20%
less | |
Last Updated: 30 May 2024
Experience | Avg Annual Salary |
---|---|
Fresher (AmbitionBox Estimate) |
₹2.5
L/yr
- ₹3.2
L/yr
|
3 years (AmbitionBox Estimate) |
₹2.1
L/yr
- ₹2.6
L/yr
|
Login to view exact salary
| |
6 years (AmbitionBox Estimate) |
₹4.2
L/yr
- ₹5.3
L/yr
|
7 years (AmbitionBox Estimate) |
₹2.6
L/yr
- ₹3.3
L/yr
|
Discover interview dos and don'ts from real experiences
Top trending discussions